Close

Orphazyme provides regulatory update from FDA on arimoclomol for Niemann-Pick disease type C

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. CSX
4. SPY
5. NFLX
6. UAL
7. ALK
8. EFX
9. TSLA
10. MU


Go back to Orphazyme provides regulatory update from FDA on arimoclomol for Niemann-Pick disease type C

Orphazyme A/S (ORPH) Sinks 54% on CRL

June 18, 2021 6:56 AM EDT

Orphazyme A/S (NASDAQ: ORPH) sinks 54% in pre-open trading announced it has... More